chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea; Shortness of breath; Coughing; This is a spontaneous report from a contactable Nurse via Pfizer sales representative. A female patient of an unspecified age received 1st dose of bnt162b2 (Pfizer-BioNTech covid-19 vaccine, Solution for injection Batch/Lot number was not reported), via an unspecified route of administration on 15Jan2021 at 12:30PM as 1st dose single for covid-19 immunisation. Medical history and concomitant medications were not reported. On 15Jan2021 at 2 PM patient experienced feeling shortness of breath and coughing and by 16Jan2021 she had severe nausea and having lots of issue. She missed the next week of work. She was still having some shortness of breath and is being followed by her primary care physician. Patient had other diagnosis that her providers felt was important for her to receive the vaccine even though they did have concerns about how she might react. Information on the Batch/Lot number has been requested. The outcome of the events shortness of breath was not recovered and outcome of coughing and severe nausea was unknown.  Follow-up attempts completed. No further information expected.
Varivax placed on 5/30/07, 2 days RTC L arm with swelling, redness and warm to touch. (70 cm length, 40 cm width). Advised warm compress and Tylenol PRN
This case was reported by a physician and described the occurrence of fatigue in a 65-year-old female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fatigue, pain in arm and foggy feeling in head. On an unknown date, the outcome of the fatigue, pain in arm and foggy feeling in head were recovered/resolved. It was unknown if the reporter considered the fatigue, pain in arm and foggy feeling in head to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The reporter reported that his close relative had the SHINGRIX vaccine and did not like the adverse effects fatigue, arm pain and foggy head that had after SHINGRIX vaccine. The events lasted for 3 days.
Pruritis; Redness around the injection site that spread down her left arm; rash appeared as a raised linear wheal with surrounding erythema; rash appears most similarly to dermatographic urticaria.; This is a spontaneous report from a contactable physician.A 14-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20May2021 at 13:45 (at the age of 14-year-old) as dose 1, single for COVID-19 immunization.The patient had no known allergies to medications, food or other products. Medical history included childhood asthma. Concomitant medications included drospirenone; ethinylestradiol betadex clathrate (YAZ) and iron supplementation (MANUFACTURER UNKNOWN).Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.It was unknown if patient received any other vaccines within four weeks prior to the vaccination.On 20May2021 at 13:45 PM, within 15 minutes of receiving the first vaccine, the patient developed pruritis and redness around the injection site that spread down her left arm. The rash appeared as a raised linear wheal with surrounding erythema, but no pain or sloughing of skin. She had no difficulty breathing, no swelling of her tongue or throat, no fevers/chills/malaise. The patient was well in the ED and the rash appears most similarly to dermatographic urticaria.Therapeutic measures were not taken as a result of the events. The events resulted in emergency room/department visit or urgent care. The patient recovered from all events in May2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
The first time I got my vaccine on April 27, 2021  I have gotten a bad rash on my right arm on April 29, 2021 than when I gotten my second vaccine on June 06, 2021. Two days later on June 08, 2021 the rash was on my left arm as well. On June 19, 2021 the rash went away on my left arm and gotten worst on my right arm. The rash is itchy and time to time I get sharp pain in my arm. I went to the doctor for the rash and talk about it. The doctor told me that I was having a allergic reaction to the vaccine that I have got. I have gotten the Moderna vaccine on my right arm both times.
tingling of the tongue, lips and gums within 5 minutes of the vaccine struggling to breath while asleep at 7:00 am on 3/18/21
Approx 6 min p/inject, pt was still sitting in chair when started getting hot, fainted in chair w/sz like activity of arms; Lasting approx 1-2min; Pt awoke very pale & diaphoretic, alert & responsive; BP 110/74; Pt walked out unassisted;
After first dose--slightly sore arm for 3 days.; This is a spontaneous report from a non-contactable non-healthcare professional. A 48-year-old non-pregnant female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: Unknown), via unspecified route on left arm on 19Jan2021 at 11:45 (at the age of 48 years) as 1st single dose for COVID-19 immunisation. The patient's medical history included allergies to freshwater prawns. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in 2021, the patient experienced slightly sore arm for 3 days. The patient has not receive any treatment. The outcome of the event was recovered on 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
"Really sore arm, shortness of breath, sharp stomach pains, light-headed, headache, slight fever, extremely weak, upset stomach, diarrhea and hurt all over (shoulders hurt the most)".
I had the flu shot on 10/16/2012 at 2 PM. (You did not administer it.) I wanted to go on record that it must have been a very strong lot. I was feeling sick by 4:30 PM and it got worse from there. By 5:30 PM, when I left work, I wasn't sure to ask for a ride or go to the ER.  I've never been so sick in 50 years. I felt if I gave in I'd pass out for sure. I drove home hugging the wheel. (Thinking I'd talk myself out of the feeling and a bit embarrassed over it.) By the time I arrived home I was projectile vomiting and diarrhea along with my head spinning. This went on till 3 AM Wednesday morning. I didn't feel somewhat normal till 11:30 AM Wednesday.
slight headache/bad headache; trouble breathing; fever; chills; vomiting; a feeling of rubbery legs; Stayed in bed Wed and Thurs; She had been spending time with her boyfriend and her family. It turned out her boyfriend and his family all have had COVID; This is a spontaneous report from a contactable consumer via Pfizer sales representative. This consumer reported for 16-year-old female patient (grandniece) that:  A16-year-old female patient received dose 1, single BNT162B2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: 0158) via unspecified route of administration, on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient had experienced slight headache/bad headache after receiving her first injection. She also experienced trouble breathing, fever, chills, vomiting and a feeling of rubbery legs. She spent time with her boyfriend and her family, it turned out her boyfriend and his family all had COVID, on an unspecified date. The outcome for the event She had been spending time with her boyfriend and her family. It turned out her boyfriend and his family all have had COVID was unknown and rest all the events was recovered on an unspecified date.  No follow-up attempts are needed. No further information is expected.
Patient called pharmacy and reported a grapefruit sized rash two inches below injections site that was warm to touch with slight swelling. Patient did not feel sick.
Patient stated that next day her lymph node in neck swelled and lasted about 5 to 7 days. Patient  did mention swelling to her physician,. Patient stated also broke out with impetigo on facial area, but said physician couldn't say for sure if that was related to the vaccine. Patient also mentioned that she is prone to swelling of lymph nodes in the past. She did not require hospitalization or medical treatment. She self treated at home with cold compresses for swelling on neck and  was prescribed mupirocin ointment for impetigo
Pt recvd 1st Hep B vax 20MAY91 & was uneventful; Recvd 2nd Engerix-B vax 17JUN91 & arm swelled, was warm & bruise devel the size of a quarter; tx ice bags;
Swelling of the face around cheeks and chin - right side greater than left. No pain or discomfort.  Just swelling.
elevated temp & sz w/in 18hr of vax being given;transferred by amb to ED;eval no tx other than antipyretics given;
Information has been received from a Registered Nurse concerning a 74 year old female patient who on 11-OCT-2010 was vaccinated intramuscularly with a 0.5 ml dose of PNEUMOVAX 23 (Lot# 667445/0993Z) (Expiration date: 05-JAN-2012). The nurse reported that on 11-OCT-2010, the patient's upper left arm was swollen, red, warm and tender. The nurse also stated that the patient reported body aches. At the time of the report, the patient was recovering. The patient sought unspecified medical attention. Follow up information has been received from a physician concerning the 74 year old retired female patient with emphysema, constipation, neuropathy, atrial fibrillation, gastrooesophageal reflux disease, hypothyroidism, iron deficiency, anaemia and allergy to codeine, MUCINEX and VANEX-LA and no illness at the time of vaccination on 08-MAR-2010 was vaccinated IM with the first dose of PNEUMOVAX 23 (Lot # and route not reported) and on 11-OCT-2010 at 10:25 was vaccinated intramuscularly with a 0.5 ml dose of PNEUMOVAX 23 (Lot# 667445/0993Z) (Expiration date: 05-JAN-2012). It was reported that on 12-OCT-2010, in the morning the patient experienced injection side red on her left upper arm, warm, and swollen, low grade fever and body aches. On approximately 13-OCT-2010 the patient had recovered. Additional information is not expected.
Both regular vaccine (FLUVIRIN) and pneumovax 23  administer to L deltoid. 9/30/08 reported to ED with cellulitis to L upper arm.
Diffuse swelling of LUE with minimal swelling LLE and hand area hot to touch (LUE). Not inflamed. Painful-child not moving arm. Seen in ER prescribed antibiotic treating pos cellulitis. Mother has been advised child has an egg allergy not known to her. Medical records state anemia, bacterial infection
Pityriasis rosea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient in her 20's received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PITYRIASIS ROSEA (non-serious), outcome "unknown", described as "Pityriasis rosea".  Additional information: One developed pityriasis rosea immediately after the injection. Event took place after use of product. The patient did not think it was the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
ADMITTED ON 10/18/2021: Chief Complaint:  Stroke alert  Historian:  Patient arrived the ER via EMS secondary to stroke-like symptoms that began earlier today.  Patient met in CT on arrival.  Per EMS patient had called family member at around 3:00 p.m. and told them that she had weakness and did not feel "right".  On arrival to the ER patient noted to have some difficulty with her speech and at several points in conversation inserted words that had no relevance to conversation.  Patient also became frustrated couple of times because she was having difficulty expressing her thoughts with speech.  Patient also complains of right-sided weakness, this was also noted by EMS. PT IS CURRENT INPATIENT.
Red spots appeared on child's chest, right axillia back, waist line, diaper line in the evening on 2/18/2010- Suggested to notify people she had contact with, the day care was notified and she is to remain away from the day care until scabs appear.
At the 12 minute wait mark a mushroom of pain exploded/bloomed in top of L arm. It eased off to soreness The next day my left underarm lymph swelled/painful, the day after that R underarm lymph joined in. Then groin lymph joined in for a few more days. My right scapula started hurting and the area of bra strap across back had fiery pain (like the fire pain when I was floxed from cipro) My heart was racing for weeks also.
Patient is a 69 y.o. female with a past medical history that includes granulomatosis with polyangiitis w/ kidney and sinus involvement, hx of DVT 11/2021 on eliquis, meningioma, migraines, rectocele, multiple lung nodules, HTN, CKD IV on TThS dialysis, HFpEF and MVR and AVR,  who recently underwent aortic valve and mitral valve replacement and tricuspid valve repair at clinic 11/8/22.  She presented on 12/22/2022 for increasing oxygen requirements, COVID, and shortness of breath. Intubated on 12/22. Initially on iHD then CRRT for volume removal. Unable to wean off ventilatory support despite multiple therapies, volume removal, medical optimization. Patient required pressor support for hypotension, likely multifactorial in etiology. She was an an initial course of vancomycin and zosyn, then ultimately weaned off due to more viral picture. However patient while in the ICU developed a new episode of severe shock, therefore meropenem was initiated.  Patient required small volume resuscitation, however patient's respiratory status appeared to be tenuous with small amounts of fluid resuscitation for shock.  Course complicated with suspected GI bleed, GI initially requested EGD, however goals of care discussion were made and this was deferred.  Multiple ongoing goals of care discussions were made with family. Patient stated multiple times that she did not want to be on prolonged ventilator support.  Ultimately patient and family decided that patient would want to focus on comfort, especially given declining overall medical prognosis, and overall health fragility.  Therefore patient being DNR CCA, once family visited, patient transition to comfort care with compassionate extubation.
PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no previous medical conditions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 10:40 to Right Arm for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced pain at injection site. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from pain at injection site. This report was non-serious.
I gave the patient 0.3ml of undiluted Pfizer Covid19  vaccine. I realized what had happened about an hour later. I contacted the Pfizer help line to get info on what to do and what to expect. They gave me a little info about when it happened before and patients could experience severe side effects. I tried to contact patients mom but couldnt get her. The mom came in the pharmacy the next day so I was able to tell her what happened. She said he was extremely sore but was ok. I saw the patient a few days later and he was doing fine.
Patient was vaccinated and within just a few minutes of vaccine administration began to feel throat tightening, difficulty getting air, tachycardia, and dry mouth. Admitted to a past history of anaphylaxis with shell fish and endorses similar symptoms. Employee was treated with an epi pen and taken to the emergency room for additional monitoring and treatment as needed Treatment dugs:
Patient states she had four eruptions on her right buttocks after receiving SHINGRIX immunization.  One area of involvement had a "big blister". Doctor was visited 6/12/18 and patient was diagnosed with Shingles. This is an unconfirmed patient report. Patient also had the expected arm pain which persisted for 3 to 4 days.
patient describes a numb feeling on the left side of her face and a tingly sensation in the lips approx 5 minutes after vaccine
The patient received both her annual flu vaccine and the ZOSTAVAX prescribed by her doctor. She initially felt ok shortly after the injections and was planning to head home. She came back soon after before leaving the store stating that she felt nauseous and dizzy. She sat at the pharmacy for a bit and we gave her some water. She eventually said her symptoms were getting better and she was going to go home for the evening. I called her at home later on to check on her and she said she had gotten some more water and rested awhile and then she was feeling much better and no longer had any dizziness or nausea.
Fever; Injection site pain; Feeling unwell; Tiredness; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling unwell), FATIGUE (Tiredness), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B2114) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulfa products). Concomitant products included CHLORPHENAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (MULTI SYMPTOM TYLENOL COLD) for an unknown indication.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced MALAISE (Feeling unwell), FATIGUE (Tiredness), HEADACHE (Headache) and CHILLS (Chills). On an unknown date, the patient experienced PYREXIA (Fever) and INJECTION SITE PAIN (Injection site pain). At the time of the report, MALAISE (Feeling unwell), FATIGUE (Tiredness), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever) and INJECTION SITE PAIN (Injection site pain) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.
Patient Started with head jerking and staring into space. Not really responsive for 3 weeks. Also had unsteady gait and was falling all of the time from 02/20/16 - 04/10/2016. On April 10th patient had uncontrollable crying and on set of diarrhea this continued until May 4th. During this time she also had an unexplainable rash head to toe and the mouth rash just cleared up o May 7th, 2016. The loose stool is still on and off but finally subsiding. Patient also had lose of appetite and lost weight at the time of all this. Symptoms kept popping up over a two month time periods. After speaking with Dr today on May 10th she agrees a possible reaction has taken place. The parents believe that is it all related to either the MMR and/or Hep A Vaccine .
This case was reported by a nurse via call center representative and described the occurrence of erythema multiforme in a 16-month-old male patient who received FLULAVAL Quadrivalent (batch number 354H9, expiry date 30th June 2018). On 31st October 2017, the patient received the 1st dose of FLULAVAL Quadrivalent .5 ml. On 2nd November 2017, 2 days after receiving FLULAVAL Quadrivalent, the patient experienced erythema multiforme (serious criteria GSK medically significant), rash and skin lesion. On an unknown date, the patient experienced generalized erythema. The patient was treated with ZYRTEC and prednisolone. On an unknown date, the outcome of the erythema multiforme, rash, generalized erythema and skin lesion were unknown. It was unknown if the reporter considered the erythema multiforme, rash, generalized erythema and skin lesion to be related to FLULAVAL Quadrivalent. Additional details were reported as follows: At 04:00, the patient received FLULAVAL Quadrivalent. On 2nd November 2017, Thursday, the patient experienced rash. The physician diagnosed it as erythema multiforme. The patient was seen in the office on Friday as the rash had progressed. The reporter read the notes from the physician assistant who observed the patient and the notes included the sporadic erythematous raised circular lesions 1 by 1 cm on body. There was no central clearing, vesicles, crusting. A throat culture was taken which resulted negative.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history or concurrent conditions was provided. In approximately January 2016, reported as multiple unspecified dates following a temperature excursion reported on 15-JAN-2016, the patients were vaccinated with improperly stored doses of ZOSTAVAX injection (lot# reported as L027327, expiry date 21-OCT-2016; dose and route of administration were not reported). There were no concomitant therapies reported. No adverse effects were reported. There was no product quality complaint involved. The reporter stated that the doses of ZOSTAVAX were exposed to the temperature of 6.1 degrees Fahrenheit for a period of 70 hours on an unknown date (with previous temperature excursions: 5.9 degrees Fahrenheit for 15 hours, 6.8 degrees Fahrenheit for 48 hours, 5.5 degrees Fahrenheit for 72 hours, 6.8 degrees Fahrenheit for 15 hours, 6.6 degrees Fahrenheit for 120 hours, 5.9 degrees Fahrenheit for 72 hours, 5.2 degrees Fahrenheit for 16 hours and 6.1 degrees Fahrenheit for 70 hours- on unspecified dates). This is one of several reports received from the same reporter. Additional information has been requested.
Heavier than usual period with extra-large blood clots. Every period since second dose has had abnormally large clots and significantly heavier than before.
Day after the second shot, I ran a high fever that lasted only one day.   Afterward, i started to notice a ringing in ears. and it continues through today.
This spontaneous report as received from a physician refers to a 4 month old infant patient. Drug allergies, reactions or medical history were not reported. On 26-FEB-2014, the patient received two doses of oral ROTATEQ. One expired dose of 2 ml of oral ROTATEQ (oral, lot # H010052, expiration date 02-NOV-2013) and one doe of 2 ml of oral ROTATEQ (lot #, expiration date and not reported) that was not expired. No concomitant medications were reported. No adverse effect reported. This case is linked to the same reporter cases MARRS # 1402USA013518, 1402USA013519 and 1402USA013520. Additional information has been requested.
I was diagnosed with shingles two days ago by my Dr. He gave three prescriptions ... Acyclovir 800 mg five times daily, hydrocodone 325 for pain and a shot .... ZOSTAVAX. The pharmacist administered the injection. My symptoms are worse including extreme back pain and leg pain. Also the breakout blistered areas are much worse. Terrible reaction.
Left upper arm pink warm around injection site-5 inches diameter. Pt c/o itching.